Pulmonaryhypertensionnews.com6h
Winrevair regimen balances efficacy, safety in PAH: Analysis
The dosing regimen for Winrevair is optimal for balancing safety and effectiveness in adults with PAH, according to clinical ...
Pulmonaryhypertensionnews.com4d
PH can impose physical restrictions, but don’t limit yourself
Living with PH, it's easy to focus on what we can't do instead of what we can. Columnist Colleen Steele's advice? Don't limit ...
Pulmonaryhypertensionnews.com4d
Weight-based Uptravi dosing appropriate for PAH children: Study
A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...
Pulmonaryhypertensionnews.com7d
Phase 2 trial of tiprelestat for PAH receives FDA advice
The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...
Pulmonaryhypertensionnews.com9d
Alivegen’s ALG-801 named FDA orphan drug for PAH
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...
Pulmonaryhypertensionnews.com9d
How I struggle to manage chronic pain during the holidays
Chronic pain can be particularly difficult to manage during the holidays, says columnist Jen Cueva, who shares how PH disrupted her plans.